Loading…
Sampre Nutritions (BSE 530617)₹4.20+1.94%Packaged Foods
In the Jun 2026 quarter (consolidated), Sampre Nutritions reported sales of ₹14.84 Cr, up 36.4% from Jun 2025, and net profit of ₹0.69 Cr, down 1.4% year on year. For the year to Mar 2026, sales were ₹43.37 Cr and net profit ₹3.07 Cr.
Company filings, consolidated accounts; latest reported quarter Jun 2026
| Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4.75 | 4.50 | 7.28 | 5.57 | 7.78 | 10.88 | 9.99 | 7.40 | 15.11 | 14.84 |
| Expenses | 2.72 | 3.55 | 6.24 | 5.12 | 14.00 | 9.46 | 8.04 | 5.89 | 14.63 | 13.31 |
| Operating Profit | 2.04 | 0.96 | 1.02 | 0.45 | −6.29 | 1.39 | 1.95 | 1.49 | 0.44 | 1.51 |
| OPM % | 42.7% | 21.1% | 13.9% | 7.9% | −80.6% | 12.7% | 19.5% | 20.1% | 2.9% | 10.1% |
| Other Income | 0.08 | 0.02 | 0.00 | 0.03 | 0.30 | 0.02 | 0.00 | 0.00 | 0.66 | 0.06 |
| Interest | 0.49 | 0.46 | 0.46 | 0.60 | 0.59 | 0.32 | 0.29 | 0.27 | 0.52 | 0.27 |
| Depreciation | 0.93 | 0.45 | 0.45 | 0.45 | 0.67 | 0.40 | 0.62 | 0.51 | 0.55 | 0.52 |
| Profit before tax | 0.71 | 0.08 | 0.11 | −0.54 | −7.17 | 0.70 | 1.05 | 0.71 | 0.04 | 0.79 |
| Tax % | 36.0% | 0.0% | 0.0% | 0.0% | 2.1% | 0.0% | 16.0% | 13.9% | −2,600.0% | 12.5% |
| Net Profit | 0.46 | 0.09 | 0.11 | −0.53 | −7.34 | 0.70 | 0.89 | 0.61 | 1.34 | 0.69 |
| EPS (Rs) | 0.17 | 0.04 | 0.04 | −0.09 | −0.89 | 0.09 | 0.11 | 0.08 | 0.15 | 0.08 |
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|
| Sales | 37.08 | 25.13 | 25.13 | 43.37 | 47.34 |
| Expenses | 32.96 | 20.95 | 28.88 | 38.46 | 41.87 |
| Operating Profit | 4.07 | 4.13 | −3.86 | 4.80 | 5.39 |
| OPM % | 11.0% | 16.4% | −15.3% | 11.1% | 11.4% |
| Other Income | 0.06 | 0.11 | 0.36 | 0.42 | 0.72 |
| Interest | 1.90 | 1.93 | 2.08 | 1.40 | 1.35 |
| Depreciation | 1.83 | 1.84 | 1.98 | 2.06 | 2.20 |
| Profit before tax | 0.41 | 0.48 | −7.49 | 1.76 | 2.59 |
| Tax % | 16.6% | 53.0% | 2.0% | −73.5% | — |
| Net Profit | 0.34 | 0.22 | −7.66 | 3.07 | 3.53 |
| EPS (Rs) | 0.14 | 0.09 | −0.92 | 0.33 | 0.42 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Equity Capital | 6.86 | 7.28 | 21.02 | 47.50 |
| Reserves | 14.31 | 15.22 | 69.94 | 59.94 |
| Borrowings | 16.76 | 17.46 | 16.88 | 17.90 |
| Other Liabilities | 5.69 | 4.78 | 7.64 | 9.16 |
| Total Liabilities | 43.62 | 44.74 | 115 | 135 |
| Fixed Assets | 20.48 | 21.02 | 19.80 | 20.04 |
| CWIP | 4.15 | 5.48 | 4.99 | 5.00 |
| Investments | 0.02 | 0.02 | 73.60 | 83.57 |
| Other Assets | 18.97 | 18.22 | 17.09 | 25.89 |
| Inventories | 7.02 | 7.55 | 5.69 | 7.57 |
| Trade receivables | 7.44 | 6.70 | 8.82 | 13.25 |
| Cash & equivalents | 0.14 | 0.29 | 0.24 | 0.09 |
| Total Assets | 43.62 | 44.74 | 115 | 135 |
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Cash from operating activity | 0.87 | 3.94 | 0.07 | −1.09 |
| Cash from investing activity | −4.33 | −3.71 | −75.30 | −2.76 |
| Cash from financing activity | 3.47 | −0.08 | 74.98 | 3.69 |
| Net cash flow | 0.05 | 0.17 | −0.06 | −0.16 |
| Capex | 4.43 | 3.72 | 0.29 | 2.30 |
| Free cash flow | −3.43 | 0.23 | −0.21 | −3.38 |
| CFO / OP % | 28.0% | 91.0% | −5.0% | −23.0% |
| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| Debtor days | 73 | 98 | 129 | 112 |
| Inventory days | 168 | 551 | 248 | 185 |
| Days payable | 91 | 149 | 198 | 134 |
| Cash conversion cycle | 151 | 501 | 180 | 164 |
| Working capital days | 49 | 50 | 29 | 72 |
| ROCE % | — | 6.2% | −7.4% | 2.7% |
For the Jun 2026 quarter, Sampre Nutritions reported sales of ₹14.84 Cr, up 36.4% year on year and net profit of ₹0.69 Cr, down 1.4% year on year. The operating margin was 10.1%.
Sampre Nutritions' sales for the year to Mar 2026 were ₹43.37 Cr; over the last twelve months they were ₹47.34 Cr.
Net profit for the year to Mar 2026 was ₹3.07 Cr, and ₹3.53 Cr over the last twelve months. Earnings per share over the same trailing period were ₹0.42.
Sampre Nutritions reported borrowings of ₹17.90 Cr at Mar 2026, against cash and equivalents of ₹0.09 Cr.
Cash from operations was −₹1.09 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹3.38 Cr.